Analyzing Generics Market in Italy 2017

  • ID: 4384133
  • Report
  • Region: Italy
  • 85 Pages
  • Aruvian's R'search
1 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Mylan N.V.
  • Sandoz International GmbH
  • Sanofi SA
  • MORE

The Italian generics industry has been growing strongly in the recent years. The market had revenues of over USD 1 billion in 2016 and there is plenty of scope for expansion in the market as the generics volume in the country remains relatively low. By 2021, the market is expected to cross a value of over USD 5 billion.

Analyzing Generics Market in Italy 2017 is a comprehensive coverage of the Italian generic drugs market. Beginning with a sectional description on the global generic industry, the report looks at an overview of the industry, an analysis of the market volume and value, industry segmentation and an industry forecast.

Moving on, we analyze the Generics Industry in Europe through the same parameters.

The Generics Industry in Italy is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.

We also include a Porter’s Five Forces analysis of the Italian Generics Industry. Generics pricing and reimbursement situation in Italy and trends and challenges facing the industry are analyzed.

Analysis of the major industry players in the Italian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Mylan NV, Sandoz International, Sanofi and others. This concludes this comprehensive research report.

This research report helps you get an insider’s look at the Italian generic industry and helps you understand what the future holds for the industry. Regulatory framework, pricing and reimbursement scenarios, comparison of the Italian market with its regional counterparts, all these data points makes this report an essential resource for analytical purposes.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Mylan N.V.
  • Sandoz International GmbH
  • Sanofi SA
  • MORE

A. Executive Summary

B. Analyzing the Global Generics Industry
B.1 Industry Definition
B.2 Industry Overview
B.3 Industry Value & Volume Analysis
B.4 Industry Segmentation by Geography
B.5 Patent Expiries
B.6 Global Generic Industry Structure
B.7 Industry Forecast

C. Generics Industry in Europe
C.1 Industry Overview
C.2 Industry Value & Volume
C.3 Industry Segmentation by Geography
C.4 Industry Forecast

D. Generics Industry in Italy
D.1 Industry Overview
D.2 Industry Value & Volume
D.3 Industry Segmentation by Geography
D.4 Industry Forecast

E. Generics Industry in Italy: Porter’s Five Forces Strategy Analysis
E.1 Introduction
E.2 Bargaining Power of Buyers
E.3 Bargaining Power of Suppliers
E.4 Competitive Rivalry in the Industry
E.5 Threat of New Entrants
E.6 Threat of Substitutes

F. Pricing & Reimbursement in Italy
F.1 Overview
F.2 Generics Pricing & Reimbursement Scenario
F.3 Trends & Challenges

G. Major Industry Players
G.1 Allergan Plc
G.1.1 Corporate Analysis
G.1.2 Financial Analysis
G.1.3 SWOT Analysis
G.2 Mylan N.V.
G.2.1 Corporate Analysis
G.2.2 Financial Analysis
G.2.3 SWOT Analysis
G.3 Sanofi SA
G.3.1 Corporate Analysis
G.3.2 Financial Analysis
G.3.3 SWOT Analysis
G.4 Teva Pharmaceutical Industries Limited
G.4.1 Corporate Analysis
G.4.2 Financial Analysis
G.4.3 SWOT Analysis
G.5 Sandoz International GmbH

H. Glossary of Terms

List of Figures
Figure 1: Historical Revenues of Leading Generic Companies (in USD Million), 2008-2009
Figure 2: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Figure 3: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Figure 4: Global Generics Market Segmentation by Geography (%), 2016
Figure 5: Revenues of Top 10 Drugs that went off Patent between 2010-2014 (in USD Million)
Figure 6: Market Share of Leading Generic Companies Worldwide (%), 2016
Figure 7: Comparison of Revenues of Leading Generic Companies (in USD Million), 2013-2014
Figure 8: Global Generics Industry Forecast (in USD Billion), 2016-2021
Figure 9: Global Generics Industry Forecast by Volume (% of Pharma Volume), 2016-2021
Figure 10: Value of the European Generics Market (in USD Billion), 2012-2016
Figure 11: Volume Growth of the European Generics Market (%), 2012-2016
Figure 12: Share of the European Generics Industry by Countries (%), 2016
Figure 13: Forecast of the European Generics Market (in USD Billion), 2016-2021
Figure 14: Volume Forecast of the European Generics Market (%), 2016-2021
Figure 15: Value of the Generics Market in Italy (in USD Billion), 2012-2016
Figure 16: Volume Growth of the Generics Market in Italy (%), 2012-2016
Figure 17: Share of Italy in the European Generics Industry (%), 2016
Figure 18: Forecast of the Generics Market in Italy (in USD Billion), 2016-2021
Figure 19: Volume Forecast of the Generics Market in Italy (%), 2016-2021
Figure 20: Porter's Five Forces Strategy Analysis of the Generics Industry in Italy
Figure 21: Bargaining Power of Buyers in the Italian Generics Industry
Figure 22: Bargaining Power of Suppliers in the Italian Generics Industry
Figure 23: Competitive Rivalry in the Italian Generics Industry
Figure 24: Threat of New Entrants to the Italian Generics Industry
Figure 25: Threat of Substitutes to the Italian Generics Industry
Figure 26: Revenues & Profitability of Allergan Plc (in USD Million), 2011-2015
Figure 27: Revenues & Profitability of Sanofi SA (in USD Million), 2011-2015
Figure 28: Revenues & Profitability of Teva Pharmaceutical (in USD Million), 2011-2015

List of Tables
Table 1: Growth of the Global Generics Industry by Value (in USD Billion), 2012-2016
Table 2: Generics Percentage of Total Pharmaceutical Volume & Market Volume of Global Generics Industry (%), 2012-2016
Table 3: Global Generics Industry, Segmentation by Geography (in USD Billion), 2016
Table 4: Global Generics Industry Forecast (in USD Billion), 2016-2021
Table 5: Global Generics Industry Forecast by Volume & Percentage Growth (% of Pharma Volume), 2016-2021
Table 6: Value of the European Generics Market (in USD Billion), 2012-2016
Table 7: Volume Growth of the European Generics Market (%), 2012-2016
Table 8: Share of the European Generics Industry by Countries (% & USD Billion), 2016
Table 9: Forecast of the European Generics Market (in USD Billion), 2016-2021
Table 10: Volume Forecast of the European Generics Market (%), 2016-2021
Table 11: Value of the Generics Market in Italy (in USD Billion), 2012-2016
Table 12: Volume Growth of the Generics Market in Italy (%), 2012-2016
Table 13: Share of Italy in the European Generics Industry (% & USD Billion), 2016
Table 14: Forecast of the Generics Market in Italy (in USD Billion), 2016-2021
Table 15: Volume Forecast of the Generics Market in Italy (%), 2016-2021
Table 16: Key Financials of Allergan Plc (in USD Million), 2011-2015
Table 17: Key Financials of Sanofi SA (in USD Million), 2011-2015
Table 18: Key Financials of Teva Pharmaceutical (in USD Million), 2011-2015

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Allergan Plc
  • Mylan N.V.
  • Sandoz International GmbH
  • Sanofi SA
  • Teva Pharmaceutical Industries Limited
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll